Subsecond FFT‐adsorptive Voltammetric Technique as a Novel Method for Subnano Level Monitoring of Piroxicam in its Tablets and Bulk Form at Au Microelectrode in Flowing Solutions

Abstract In this work a novel method for the determination of piroxicam in flow‐injection systems has been developed. A system using fast Fourier transform continuous cyclic voltammetry (FFTCV), at a gold microelectrode in flowing solution, was used for determining piroxicam in its pharmaceutical formulations. The developed technique is very simple, precise, accurate, time saving, and economical, compared to all of the previously reported methods. The effects of various parameters on the sensitivity of the method were investigated. The best performance was obtained with a pH value of 2, scan rate value of 40 V/s, accumulation potential of (400) mV, and accumulation time of 0.4 s. The proposed method has some advantages over other reported methods, such as, no need for the removal of oxygen from the test solution, a picomolar detection limit, and finally that the method is fast enough for the determination of any such compound, in a wide variety of chromatographic methods. To obtain a sensitive determination, the integration range of currents was set for all the potential scan ranges, including oxidation and reduction of the Au surface electrode, while performing the measurements. The potential waveform, consisting of the potential steps for cleaning, accumulation, and potential ramp of analyte, was applied on an Au disk microelectrode (with a 12.5 µm in radius) in a continuous way. The method was linear over the concentration range of 1.5–364000 pg/ml (r=0.998) with a limit of detection and quantitation of 0.33 and 1.5 pg/ml, respectively. The method has the requisite accuracy, sensitivity, precision, and selectivity to assay piroxicam in tablets.

[1]  N. V. Chandrasekharan,et al.  COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: Cloning, structure, and expression , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[2]  J Ermer,et al.  Validation in pharmaceutical analysis. Part I: an integrated approach. , 2001, Journal of pharmaceutical and biomedical analysis.

[3]  M. Ganjali,et al.  Sub-Second Accumulation and Stripping for Pico-Level Monitoring of Amikacin Sulphate by Fast Fourier Transform Cyclic Voltammetry at a Gold Microelectrode in Flow-Injection Systems , 2005 .

[4]  Thomas Lisec,et al.  Microelectrode arrays and application to biosensing devices , 1994 .

[5]  J. Mazuski,et al.  The role of cyclooxygenase enzymes in the growth of human gall bladder cancer cells. , 2000, Carcinogenesis.

[6]  P. Vavia,et al.  Stability indicating HPTLC determination of piroxicam. , 2000, Journal of pharmaceutical and biomedical analysis.

[7]  A. Olivieri,et al.  Spectrofluorometric determination of piroxicam. , 1998, Journal of pharmaceutical and biomedical analysis.

[8]  G. M. Escandar,et al.  Two different strategies for the fluorimetric determination of piroxicam in serum. , 2003, Talanta.

[9]  Michael R. Neuman,et al.  Microfabricated sensor arrays sensitive to pH and K+ for ionic distribution measurements in the beating heart , 1995 .

[10]  Dong Won Jeong,et al.  Simultaneous determination of piroxicam, meloxicam and tenoxicam in human plasma by liquid chromatography with tandem mass spectrometry. , 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[11]  G. Shabir,et al.  Validation of high-performance liquid chromatography methods for pharmaceutical analysis. Understanding the differences and similarities between validation requirements of the US Food and Drug Administration, the US Pharmacopeia and the International Conference on Harmonization. , 2003, Journal of chromatography. A.

[12]  J. Morrow,et al.  Meloxicam inhibits the growth of colorectal cancer cells. , 1998, Carcinogenesis.

[13]  I. Panderi,et al.  Determination of piroxicam and its major metabolite 5-hydroxypiroxicam in human plasma by zero-crossing first-derivative spectrophotometry. , 1998, Journal of pharmaceutical and biomedical analysis.

[14]  Tau Fluvalinate,et al.  The European Agency for the Evaluation of Medicinal Products , 1997 .

[15]  S. Santoyo,et al.  Sensitive LC determination of piroxicam after in vitro transdermal permeation studies. , 2001, Journal of pharmaceutical and biomedical analysis.

[16]  P. Engstrom,et al.  Chemoprevention of cancer. , 1994, Current problems in cancer.

[17]  Ralph E. White,et al.  Comprehensive Treatise of Electrochemistry , 1981 .

[18]  J. Fernández,et al.  Piroxicam quantitation in human plasma by high-performance liquid chromatography with on- and off-line solid-phase extraction. , 1999, Journal of Chromatography A.

[19]  M. Ganjali,et al.  Fourier transform cyclic voltammetric technique for monitoring ultratrace amounts of salbutamol at gold ultra microelectrode in flowing solutions. , 2005, Talanta.

[20]  N. Ertaş,et al.  Quantitative determination of piroxicam in a new formulation (piroxicam-beta-cyclodextrin) by derivative UV spectrophotometric method and HPLC. , 2001, Journal of pharmaceutical and biomedical analysis.

[21]  G. M. Escandar,et al.  Spectrofluorimetric method for the determination of piroxicam and pyridoxine , 2002 .

[22]  G. Gerhardt,et al.  Fabrication and characterization of sputtered-carbon microelectrode arrays. , 1996, Analytical chemistry.

[23]  J. Kärger Adsorption of Molecules at Metal Electrodes , 1994 .

[24]  Eric P. Achterberg,et al.  Laboratory techniques in electroanalytical chemistry , 1996 .

[25]  J. Seetharamappa,et al.  Sensitive spectrophotometric methods for the determination of amoxycillin, ciprofloxacin and piroxicam in pure and pharmaceutical formulations. , 2002, Journal of pharmaceutical and biomedical analysis.

[26]  M. Ganjali,et al.  Fast Fourier Continuous Cyclic Voltammetry at Gold Ultramicroelectrode in Flowing Solution for Determination of Ultra Trace Amounts of Penicillin G , 2006 .

[27]  J. Miller,et al.  Statistics for Analytical Chemistry , 1993 .

[28]  Y. Heyden,et al.  Guidance for robustness/ruggedness tests in method validation. , 2001, Journal of pharmaceutical and biomedical analysis.

[29]  F. E. Suliman,et al.  A sequential injection method for the determination of piroxicam in pharmaceutical formulations using europium sensitized fluorescence. , 2004, Talanta.

[30]  Sam F. Y. Li Capillary Electrophoresis: Principles, Practice and Applications , 1992 .

[31]  H. Paulus,et al.  Drugs for Rheumatic Disease , 1987 .

[32]  Manfred Paeschke,et al.  Voltammetric multichannel measurements using silicon fabricated microelectrode arrays , 1996 .

[33]  P. Ross,et al.  Adsorption of Molecules at Metal Electrodes , 1992 .

[34]  P. Norouzi,et al.  Selective and Non-Selective Determination ofHeavy Metal Ions in Flowing Solutions by Fast Stripping Cyclic Voltammetry , 2004, Analytical sciences : the international journal of the Japan Society for Analytical Chemistry.

[35]  H. Chakraborty,et al.  Incorporation of NSAIDs in micelles: implication of structural switchover in drug-membrane interaction. , 2003, Biophysical chemistry.

[36]  D. B. Hibbert,et al.  A serial array of ISEs for use in a portable battery‐powered flow injection analyzer , 1996 .

[37]  C. Reguera,et al.  Differential Pulse Voltammetric Simultaneous Determination of Four Anti‐Inflammatory Drugs by Using Soft Modelling , 2002 .

[38]  A. Badwan,et al.  High performance liquid chromatography method for determination of methyl-5-benzoyl-2-benzimidazole carbamate (mebendazole) and its main degradation product in pharmaceutical dosage forms. , 1999, Talanta.

[39]  M. Ganjali,et al.  Novel method for fast determination of ultra trace amounts of timolol maleate by continuous cyclic voltammetry at Au microelectrode in flowing injection systems , 2005 .

[40]  M. Clench,et al.  Quantitative determination of Piroxicam by TLC-MALDI TOF MS. , 2004, Journal of pharmaceutical and biomedical analysis.